Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe
- PMID: 28626830
- PMCID: PMC5463032
- DOI: 10.1016/S2468-2667(17)30074-9
Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe
Abstract
Background: Although overweight and obesity have been studied in relation to individual cardiometabolic diseases, their association with risk of cardiometabolic multimorbidity is poorly understood. Here we aimed to establish the risk of incident cardiometabolic multimorbidity (ie, at least two from: type 2 diabetes, coronary heart disease, and stroke) in adults who are overweight and obese compared with those who are a healthy weight.
Methods: We pooled individual-participant data for BMI and incident cardiometabolic multimorbidity from 16 prospective cohort studies from the USA and Europe. Participants included in the analyses were 35 years or older and had data available for BMI at baseline and for type 2 diabetes, coronary heart disease, and stroke at baseline and follow-up. We excluded participants with a diagnosis of diabetes, coronary heart disease, or stroke at or before study baseline. According to WHO recommendations, we classified BMI into categories of healthy (20·0-24·9 kg/m2), overweight (25·0-29·9 kg/m2), class I (mild) obesity (30·0-34·9 kg/m2), and class II and III (severe) obesity (≥35·0 kg/m2). We used an inclusive definition of underweight (<20 kg/m2) to achieve sufficient case numbers for analysis. The main outcome was cardiometabolic multimorbidity (ie, developing at least two from: type 2 diabetes, coronary heart disease, and stroke). Incident cardiometabolic multimorbidity was ascertained via resurvey or linkage to electronic medical records (including hospital admissions and death). We analysed data from each cohort separately using logistic regression and then pooled cohort-specific estimates using random-effects meta-analysis.
Findings: Participants were 120 813 adults (mean age 51·4 years, range 35-103; 71 445 women) who did not have diabetes, coronary heart disease, or stroke at study baseline (1973-2012). During a mean follow-up of 10·7 years (1995-2014), we identified 1627 cases of multimorbidity. After adjustment for sociodemographic and lifestyle factors, compared with individuals with a healthy weight, the risk of developing cardiometabolic multimorbidity in overweight individuals was twice as high (odds ratio [OR] 2·0, 95% CI 1·7-2·4; p<0·0001), almost five times higher for individuals with class I obesity (4·5, 3·5-5·8; p<0·0001), and almost 15 times higher for individuals with classes II and III obesity combined (14·5, 10·1-21·0; p<0·0001). This association was noted in men and women, young and old, and white and non-white participants, and was not dependent on the method of exposure assessment or outcome ascertainment. In analyses of different combinations of cardiometabolic conditions, odds ratios associated with classes II and III obesity were 2·2 (95% CI 1·9-2·6) for vascular disease only (coronary heart disease or stroke), 12·0 (8·1-17·9) for vascular disease followed by diabetes, 18·6 (16·6-20·9) for diabetes only, and 29·8 (21·7-40·8) for diabetes followed by vascular disease.
Interpretation: The risk of cardiometabolic multimorbidity increases as BMI increases; from double in overweight people to more than ten times in severely obese people compared with individuals with a healthy BMI. Our findings highlight the need for clinicians to actively screen for diabetes in overweight and obese patients with vascular disease, and pay increased attention to prevention of vascular disease in obese individuals with diabetes.
Funding: NordForsk, Medical Research Council, Cancer Research UK, Finnish Work Environment Fund, and Academy of Finland.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5463032/bin/gr1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5463032/bin/gr2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5463032/bin/gr3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5463032/bin/gr4.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5463032/bin/gr5.gif)
Comment in
-
Excess weight and multimorbidity: putting people's health experience in risk factor epidemiology.Lancet Public Health. 2017 Jun;2(6):e252-e253. doi: 10.1016/S2468-2667(17)30093-2. Epub 2017 May 19. Lancet Public Health. 2017. PMID: 29253362 No abstract available.
-
Dicksein ist schlimm, Diabetes ist schlimmer.MMW Fortschr Med. 2018 Mar;160(4):30. doi: 10.1007/s15006-018-0239-0. MMW Fortschr Med. 2018. PMID: 29508327 Review. German. No abstract available.
Similar articles
-
Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM2.5, BC, NO2, and O3: An Analysis of European Cohorts in the ELAPSE Project.Res Rep Health Eff Inst. 2021 Sep;2021(208):1-127. Res Rep Health Eff Inst. 2021. PMID: 36106702 Free PMC article.
-
Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study.Lancet Diabetes Endocrinol. 2022 Apr;10(4):253-263. doi: 10.1016/S2213-8587(22)00033-X. Epub 2022 Mar 4. Lancet Diabetes Endocrinol. 2022. PMID: 35248171 Free PMC article.
-
Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep. Report No.: 18-05239-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep. Report No.: 18-05239-EF-1. PMID: 30354042 Free Books & Documents. Review.
-
Obesity and loss of disease-free years owing to major non-communicable diseases: a multicohort study.Lancet Public Health. 2018 Oct;3(10):e490-e497. doi: 10.1016/S2468-2667(18)30139-7. Epub 2018 Sep 1. Lancet Public Health. 2018. PMID: 30177479 Free PMC article.
-
The sex-specific association between BMI and coronary heart disease: a systematic review and meta-analysis of 95 cohorts with 1·2 million participants.Lancet Diabetes Endocrinol. 2015 Jun;3(6):437-449. doi: 10.1016/S2213-8587(15)00086-8. Epub 2015 May 7. Lancet Diabetes Endocrinol. 2015. PMID: 25960160 Free PMC article. Review.
Cited by
-
Sarcopenic Obesity and Cardiovascular Disease: An Overlooked but High-Risk Syndrome.Curr Obes Rep. 2024 May 16. doi: 10.1007/s13679-024-00571-2. Online ahead of print. Curr Obes Rep. 2024. PMID: 38753289 Review.
-
Trends in body mass index in the pre-dolutegravir period in South Africa.South Afr J HIV Med. 2024 Apr 23;25(1):1523. doi: 10.4102/sajhivmed.v25i1.1523. eCollection 2024. South Afr J HIV Med. 2024. PMID: 38725702 Free PMC article.
-
Association of the CUN-BAE body adiposity estimator and other obesity indicators with cardiometabolic multimorbidity: a cross-sectional study.Sci Rep. 2024 May 8;14(1):10557. doi: 10.1038/s41598-024-52164-7. Sci Rep. 2024. PMID: 38719889 Free PMC article.
-
Chinese visceral adiposity index and its transition patterns: impact on cardiovascular and cerebrovascular diseases in a national cohort study.Lipids Health Dis. 2024 Apr 29;23(1):124. doi: 10.1186/s12944-024-02105-0. Lipids Health Dis. 2024. PMID: 38685072 Free PMC article.
-
The association between Chinese visceral adiposity index and cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national cohort study.Front Endocrinol (Lausanne). 2024 Mar 27;15:1381949. doi: 10.3389/fendo.2024.1381949. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38601202 Free PMC article.
References
-
- Glynn LG. Multimorbidity: another key issue for cardiovascular medicine. Lancet. 2009;374:1421–1422. - PubMed
-
- WHO . Global action plan for the prevention and control of noncommunicable diseases 2013–2020. World Health Organization; Geneva, Switzerland: 2013.
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources